CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)
CUSIP: 218352102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 106,815,676
- Total 13F shares
- 89,225,655
- Share change
- -4,288,647
- Total reported value
- $2,899,048,485
- Put/Call ratio
- 93%
- Price per share
- $32.49
- Number of holders
- 282
- Value change
- -$128,567,810
- Number of buys
- 135
- Number of sells
- 147
Quarterly Holders Quick Answers
What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 218352102:
Top shareholders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
16%
|
16,826,081
|
$423,848,981 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9%
|
9,565,782
|
$240,962,048 | — | 31 Mar 2024 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
7.8%
|
8,303,147
|
$209,156,000 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
6.7%
|
7,118,371
|
$179,312,000 | — | 31 Mar 2024 | |
| Parallel Advisors, LLC |
13F
|
Company |
3.6%
|
3,815,677
|
$96,116,904 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
3,575,526
|
$90,067,500 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
2,567,677
|
$64,679,784 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
13F
|
Company |
2.3%
|
2,411,362
|
$60,742,209 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
2,157,785
|
$54,362,204 | — | 31 Mar 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.7%
|
1,838,812
|
$46,319,674 | — | 31 Mar 2024 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.7%
|
1,835,093
|
$46,225,992 | — | 31 Mar 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.6%
|
1,686,671
|
$42,487,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,513,078
|
$38,114,434 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
1.4%
|
1,498,920
|
$37,757,795 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
1,133,084
|
$28,542,386 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
1,033,225
|
$26,026,938 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.9%
|
963,443
|
$24,269,129 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.87%
|
933,461
|
$23,513,882 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.8%
|
852,345
|
$21,470,570 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.77%
|
822,123
|
$20,709,278 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.77%
|
818,475
|
$20,617,385 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.72%
|
770,280
|
$19,403,354 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.71%
|
760,200
|
$19,149,438 | — | 31 Mar 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.7%
|
744,469
|
$18,753,174 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.68%
|
731,468
|
$18,425,679 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.68%
|
724,022
|
$18,238,115 | — | 31 Mar 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.63%
|
675,843
|
$17,024,484 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
673,354
|
$16,961,787 | — | 31 Mar 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.55%
|
582,355
|
$14,669,533 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.52%
|
553,007
|
$13,930,246 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.51%
|
542,178
|
$13,657,464 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.49%
|
526,138
|
$13,253,417 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.41%
|
434,722
|
$10,950,647 | — | 31 Mar 2024 | |
| BURNEY CO/ |
13F
|
Company |
0.4%
|
431,638
|
$10,872,952 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.33%
|
351,374
|
$8,851,122 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.31%
|
336,272
|
$8,470,692 | — | 31 Mar 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.3%
|
324,271
|
$8,168,000 | — | 31 Mar 2024 | |
| FAS Wealth Partners, Inc. |
13F
|
Company |
0.29%
|
311,383
|
$7,843,738 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.27%
|
292,900
|
$7,381,728 | — | 31 Mar 2024 | |
| S&T BANK/PA |
13F
|
Company |
0.27%
|
290,487
|
$7,317,000 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.26%
|
275,244
|
$6,933,396 | — | 31 Mar 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.26%
|
273,776
|
$6,896,417 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.25%
|
265,049
|
$6,676,809 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
264,309
|
$6,657,944 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
258,408
|
$6,509,297 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.24%
|
252,443
|
$6,359,040 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.23%
|
245,462
|
$6,183,188 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.22%
|
236,199
|
$5,944,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
219,037
|
$5,517,541 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.2%
|
211,592
|
$5,330,002 | — | 31 Mar 2024 |
Institutional Holders of CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) as of Q2 2024
As of 30 Jun 2024,
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,225,655 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Novo Holdings A/S, GEODE CAPITAL MANAGEMENT, LLC, and Boston Trust Walden Corp.
This page lists
282
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
283
Q2 2024 holders
282
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.